UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

Clinical and Vaccine Immunology, 2011-05, Vol.18 (5), p.730-735

2011

Volltextzugriff (PDF)

Phase I clinical trial of O -acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine

Vaccine, 2014-05, Vol.32 (22), p.2618-2622

2014

Volltextzugriff (PDF)

Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis

Clinical and Vaccine Immunology, 2012-02, Vol.19 (2), p.140-145

2012

Volltextzugriff (PDF)

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children

The Pediatric infectious disease journal, 2003-08, Vol.22 (8), p.701-706

2003

Volltextzugriff (PDF)

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

The New England journal of medicine, 2003-10, Vol.349 (14), p.1390-1391

2003

Volltextzugriff (PDF)

Protein Conjugates of Synthetic Saccharides Elicit Higher Levels of Serum IgG Lipopolysaccharide Antibodies in Mice than Do Those of the O-Specific Polysaccharide from Shigella dysenteriae Type 1

Proceedings of the National Academy of Sciences - PNAS, 1999-04, Vol.96 (9), p.5194-5197

1999

Volltextzugriff (PDF)

Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in israel

Infection and immunity, 2001-03, Vol.69 (3), p.1351-1357

2001

Volltextzugriff (PDF)

Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children

Infection and Immunity, 2004-11, Vol.72 (11), p.6586-6588

2004

Volltextzugriff (PDF)

Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines

Vaccine, 1999, Vol.17 (2), p.126-133

1999

Volltextzugriff (PDF)

Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in Mice

Infection and Immunity, 2003-09, Vol.71 (9), p.5115-5120

2003

Volltextzugriff (PDF)

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

Vaccine, 2010-03, Vol.28 (10), p.2231-2235

2010

Volltextzugriff (PDF)

Erratum to ‘Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children’ [Vaccine 28 (2010) 2231–2235]

Vaccine, 2019-08, Vol.37 (36), p.5504-5504

2019

Volltextzugriff (PDF)

O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a

Carbohydrate research, 2007-02, Vol.342 (3), p.643-647

2007

Volltextzugriff (PDF)

Phase I clinical trial ofO-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine

Vaccine, 2014-05, Vol.32 (22), p.2618

2014

Volltextzugriff (PDF)

Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids

Infection and Immunity, 1993-09, Vol.61 (9), p.3678-3687

1993

Volltextzugriff (PDF)

Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice

Infection and immunity, 1999-10, Vol.67 (10), p.5526-5529

1999

Volltextzugriff (PDF)

Binding of the O-antigen of Shigella dysenteriae type 1 and 26 related synthetic fragments to a monoclonal IgM antibody

The Journal of biological chemistry, 1993-12, Vol.268 (34), p.25797-25802

1993

Volltextzugriff (PDF)

Acetylation of the O-specific polysaccharide isolated from Shigella flexneri serotype 2a

Carbohydrate research, 2006-11, Vol.342 (3-4), p.643-647

2006

Volltextzugriff (PDF)

Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates

Infection and Immunity, 1983-04, Vol.40 (1), p.245-256

1983

Volltextzugriff (PDF)

Hypothesis for Vaccine Development: Protective Immunity to Enteric Diseases Caused by Nontyphoidal Salmonellae and Shigellae May Be Conferred by Serum IgG Antibodies to the O-Specific Polysaccharide of Their Lipopolysaccharides

Clinical infectious diseases, 1992-08, Vol.15 (2), p.346-361

1992

Volltextzugriff (PDF)

Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates

Infection and Immunity, 1984-09, Vol.45 (3), p.582-591

1984

Volltextzugriff (PDF)

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers

Infection and Immunity, 1996-10, Vol.64 (10), p.4074-4077

1996

Volltextzugriff (PDF)

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-r EPAsucc conjugate vaccines in one- to four-year-old children

The Pediatric infectious disease journal, 2003-08, Vol.22 (8), p.701-706

2003

Volltextzugriff (PDF)

Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

Infection and Immunity, 1991-12, Vol.59 (12), p.4450-4458

1991

Volltextzugriff (PDF)

Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel

Infection and Immunity, 2001-03, Vol.69 (3), p.1351

2001

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(26)
Buchkapitel
(2)

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Immunology
(14)
Microbiology
(14)
Biological And Medical Sciences
(13)
Humans
(13)
Antibodies, Bacterial - Blood
(12)
Female
(12)
Fundamental And Applied Biological Sciences. Psychology
(11)
Infectious Diseases
(11)
Polysaccharides, Bacterial - Immunology
(11)
Animals
(10)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(10)
Bacteriology
(9)
Male
(9)
Immunoglobulin G - Blood
(8)
Mice
(8)
Vaccines, Conjugate - Immunology
(7)
Adolescent
(6)
Adult
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

Phase I clinical trial of O -acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine

Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

Protein Conjugates of Synthetic Saccharides Elicit Higher Levels of Serum IgG Lipopolysaccharide Antibodies in Mice than Do Those of the O-Specific Polysaccharide from Shigella dysenteriae Type 1

Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in israel

Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children

Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines

Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in Mice

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

Erratum to ‘Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children’ [Vaccine 28 (2010) 2231–2235]

O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a

Phase I clinical trial ofO-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine

Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids

Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice

Binding of the O-antigen of Shigella dysenteriae type 1 and 26 related synthetic fragments to a monoclonal IgM antibody

Acetylation of the O-specific polysaccharide isolated from Shigella flexneri serotype 2a

Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates

Hypothesis for Vaccine Development: Protective Immunity to Enteric Diseases Caused by Nontyphoidal Salmonellae and Shigellae May Be Conferred by Serum IgG Antibodies to the O-Specific Polysaccharide of Their Lipopolysaccharides

Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-r EPAsucc conjugate vaccines in one- to four-year-old children

Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel

Suchergebnisse filtern